These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2217426)
1. Pathology of bladder cancer: assessment of the primary lesion and response to therapy. Reuter VE Prog Clin Biol Res; 1990; 353():45-56. PubMed ID: 2217426 [No Abstract] [Full Text] [Related]
2. [Comments on the contribution by S. Presse et al. Morphology of bladder cancer based on cystectomy specimen]. Mikuz G Pathologe; 1994 Feb; 15(1):63-4. PubMed ID: 8153080 [No Abstract] [Full Text] [Related]
3. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Coblentz TR; Mills SE; Theodorescu D Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of cancer of the bladder]. Escudero Barrilero A Arch Esp Urol; 1989; 42(1):1-7. PubMed ID: 2653234 [No Abstract] [Full Text] [Related]
6. Editorial: Bladder cancer. How can we make a difference? Soloway MS J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775 [No Abstract] [Full Text] [Related]
7. Management of transitional cell carcinoma of the bladder. Murshidi MS Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783 [TBL] [Abstract][Full Text] [Related]
8. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. deVere White RW; Katz MH; Steinberg GD J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209 [No Abstract] [Full Text] [Related]
9. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Scher HI J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114 [No Abstract] [Full Text] [Related]
10. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
11. Contemporary management of stage T1 transitional cell carcinoma of the bladder. Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077 [No Abstract] [Full Text] [Related]
12. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1). Prout GR; Kopp J Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913 [No Abstract] [Full Text] [Related]
13. Muscle-invasive bladder tumour: can the bladder be preserved? Sella A BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247 [No Abstract] [Full Text] [Related]
14. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma. Granfors T; Tomic R; Ljungberg B Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744 [TBL] [Abstract][Full Text] [Related]
15. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737 [TBL] [Abstract][Full Text] [Related]